CTMX experienced a dramatic financial turnaround with stockholders' equity swinging from negative $456K to positive $99M while operating performance deteriorated significantly with revenue declining 45% and the company returning to substantial losses.
The massive equity improvement suggests a major financing event or debt restructuring that resolved the company's negative equity position, but this came alongside a severe deterioration in operating fundamentals. The sharp decline in revenue and return to significant losses indicates potential setbacks in their clinical programs or partnerships, creating uncertainty about the sustainability of their improved balance sheet position.
CTMX underwent a dramatic financial transformation with stockholders' equity surging over 21,000% from deeply negative territory to $99M, likely from equity financing that also enabled a 57% reduction in total liabilities. However, operating performance collapsed with revenue falling 45% to $76M and the company swinging from $32M profit to $17M loss, suggesting significant business headwinds. Despite cash declining 67% to $13M, current assets grew 34% overall, but the combination of deteriorating operations and reduced cash runway presents liquidity concerns going forward.
Equity base grew 21812.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Net income declined 154.5% — review whether driven by operations, interest costs, or non-recurring items.
Cash declined 66.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Liabilities reduced 56.6% — deleveraging improves balance sheet strength and financial flexibility.
Current liabilities reduced — improved short-term financial position and working capital health.
Revenue declined 44.8% — significant demand weakness or market share loss warrants investigation.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Current assets grew 34.1% — improving short-term liquidity or inventory/receivables build.
Capex reduced 29% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →